• Itaconic Acid-Mediated TBK1 Inhibition Links Metabolism to I

  2026-04-30

  Chai et al. unveil how the IRG1-itaconic acid axis restrains excessive type I interferon (IFN-I) responses by alkylating TBK1 at Cys605, disrupting its activation. This mechanistic insight offers a metabolic feedback model for immune regulation and introduces itaconic acid-based TBK1 inhibitors as potential therapeutics for IFN-I-driven hyperinflammation.

• Mdivi-1: Selective DRP1 Inhibitor Transforming Apoptosis Ass

  2026-04-29

  Mdivi-1, a selective DRP1 inhibitor from APExBIO, enables precise dissection of mitochondrial fission and apoptosis in both cell and animal models. By integrating recent co-metabolomics insights, this guide outlines how to optimize your mitochondrial dynamics research, troubleshoot common pitfalls, and leverage novel workflow advances for neuroprotection and beyond.

• Meropenem Trihydrate: Benchmarks for Carbapenem Antibiotic R

  2026-04-29

  Meropenem trihydrate is a broad-spectrum carbapenem antibiotic with efficacy against gram-negative and gram-positive pathogens. It exhibits low MIC90 values and high stability for research workflows. Its metabolomic impact reveals critical insights into resistance phenotypes.

• SGI-1027 and Everolimus Synergy Via Lysosomal Membrane Perme

  2026-04-28

  This study demonstrates that combining the methuosis inducer SGI-1027 with everolimus enhances apoptosis and GSDME-dependent pyroptosis in renal cell carcinoma by triggering lysosomal membrane permeability. The findings reveal a novel mechanism for overcoming everolimus resistance and highlight lysosomal dynamics as a key therapeutic vulnerability.

• Caspofungin: Precision Antifungal Workflows for Candida Rese

  2026-04-28

  Caspofungin, a lipopeptide antifungal drug, empowers researchers to dissect β-(1,3)-D-glucan biosynthesis and tackle Candida resistance. This guide delivers evidence-driven workflows, protocol optimizations, and troubleshooting tips for reliable, reproducible antifungal research.

• Pol II Degradation Triggers Cell Death Beyond Transcription

  2026-04-27

  This article examines how degradation of RNA Polymerase II (Pol II) can activate cell death independently of transcriptional shutdown, as demonstrated in the referenced preprint. The findings reframe our understanding of DNA damage response and offer new directions for mechanistic cancer biology research.

• Capsaicin Beyond TRPV1: Epigenetic Modulation and Oncology I

  2026-04-27

  Explore how Capsaicin acts not only as a TRPV1 ion channel activator but as a potent KDM1A/LSD1 inhibitor, revealing new avenues in epigenetic cancer modulation. This article delivers a uniquely deep, evidence-driven analysis of Capsaicin’s dual mechanisms and translational value.

• ML133 HCl: Precision Potassium Channel Inhibition in Vascula

  2026-04-26

  ML133 HCl stands out as a highly selective potassium channel inhibitor, enabling targeted investigation of Kir2.1 function in cardiovascular and pulmonary artery smooth muscle cell research. Its robust specificity and reproducibility accelerate workflows and sharpen mechanistic insights into vascular remodeling and disease modeling.

• ATM Inhibition Promotes Macropinocytosis and Metabolic Adapt

  2026-04-25

  The referenced study uncovers how ATM kinase inhibition drives metabolic adaptation in cancer cells by inducing macropinocytosis. This mechanistic link reveals a metabolic vulnerability with implications for targeting nutrient acquisition pathways in ATM-deficient tumors.

• Spider Toxin v-Agatoxin-IVA Reveals Calcium Channel Diversit

  2026-04-24

  Sidach and Mintz's landmark study redefines the pharmacological selectivity of the spider toxin v-Agatoxin-IVA, demonstrating that its low-affinity blockade extends beyond classic P-type calcium channels to include N-type and Q-type currents in mammalian neurons. This nuanced pharmacological profiling has direct implications for both the classification of neuronal calcium channels and the design of selective neurophysiological experiments.

• Rucaparib (AG-014699): Precision PARP1 Inhibition in DNA Dam

  2026-04-24

  Rucaparib (AG-014699) empowers DNA damage response studies through unmatched PARP1 inhibition and radiosensitization, especially in PTEN-deficient cancer models. This guide details advanced workflows, optimization strategies, and practical troubleshooting to extract maximum value from APExBIO's high-performance reagent.

• Rosiglitazone (Brl-49653): Optimizing PPARγ Activation in Ad

  2026-04-23

  Rosiglitazone (Brl-49653) empowers metabolic researchers with precise, reproducible PPARγ activation, enabling advanced adipogenesis and insulin sensitivity studies. This guide translates recent breakthroughs—including functional rescue in rare PPARG variants—into actionable workflows and troubleshooting strategies.

• Optimizing Protein Extraction with Protease Inhibitor Cockta

  2026-04-23

  Ensure uncompromised protein integrity and phosphorylation status with the Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO). This EDTA-free formulation from APExBIO delivers reliable inhibition of serine, cysteine, and acid proteases—essential for advanced signaling, enzyme, and post-translational modification studies.

• Surfactant-Derived LNPs Enable Efficient mRNA Delivery to Ma

  2026-04-22

  This study establishes a dual-component lipid nanoparticle (LNP) system, leveraging surfactant-derived ionizable lipids, for safe and effective mRNA delivery into macrophages. The findings advance strategies for genetic engineering of hard-to-transfect immune cells, with implications for both therapeutic development and transfection assay optimization.

• ARCA EGFP mRNA: Optimizing Fluorescence-Based Transfection C

  2026-04-22

  ARCA EGFP mRNA sets a new benchmark for fluorescence-based transfection assays in mammalian cells, enabling direct, quantitative assessment of gene delivery efficiency. Discover streamlined workflows, troubleshooting strategies, and comparative insights rooted in recent advances in nanoparticle-mediated nucleic acid delivery.

15714 records 1/1048 page Next 12345 下5页 Last page